Cargando…
Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry
BACKGROUND: The pathobiology of inflammation, thrombosis, and myocardial injury associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) may be assessed by circulating biomarkers. However, their relative prognostic importance has been incompletely described. METHODS: We analyzed d...
Autores principales: | Bhatt, Ankeet S., Daniels, Lori B., de Lemos, James, Goodrich, Erica, Bohula, Erin A., Morrow, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846881/ https://www.ncbi.nlm.nih.gov/pubmed/36669711 http://dx.doi.org/10.1016/j.ahj.2022.12.014 |
Ejemplares similares
-
Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry
por: Bhatt, Ankeet S., et al.
Publicado: (2022) -
A current review of COVID-19 for the cardiovascular specialist
por: Lang, Joshua P., et al.
Publicado: (2020) -
Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry
por: Sammour, Yasser M., et al.
Publicado: (2023) -
Initial Findings From the North American COVID-19 Myocardial Infarction Registry
por: Garcia, Santiago, et al.
Publicado: (2021) -
TRENDS AND FACTORS ASSOCIATED WITH PROPHYLACTIC ANTICOAGULATION STRATEGIES IN COVID-19: AN ANALYSIS OF THE AHA COVID-19 CVD REGISTRY
por: Lopes, Mathew, et al.
Publicado: (2023)